Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Purpose. The purpose of this study was to develop a polymeric sustained delivery system for recombinant human bone morphogenetic protein-2 (BMP-2) and to evaluate local bone growth induced by the sustained release of BMP-2 in an animal model.
Methods. BMP-2 was incorporated in biodegradable poly(D,L-lactide-co-glycolide) (PLGA) microspheres to obtain different release rates. Two sustained and an immediate release implants were produced by suspending the BMP-2 loaded PLGA microspheres in aqueous sodium carboxymethylcellulose (CMC), lyophilizing, and cutting the dried materials to the size of the animal bone defects. The local in vivo release at the implantation site in rat calvarial defects was determined by gamma scintigraphy using radiolabeled BMP-2. The local bone induction in the critical size of rabbit calvarial defects was evaluated six weeks post implantation.
Results. The immediate release implant showed about 65% initial drug release within 24 h and the remaining BMP-2 quickly exhausted from the implantation site within 7 days. The sustained release implants, showing 45-55% initial release followed by a prolonged release for 21 days, released a greater amount of BMP-2 at the implantation site and maintained higher serum BMP-2 for the longer period of time compared to the immediate release implant. Significant bone growth was observed in all BMP-2 treated defects while the defects without treatment or with BMP-2-free implant showed minimal bone healing. 75-79% of rabbit calvarial defect area was healed with newly induced bone matrix by the sustained release implants in 6 weeks as compared to 45% recovery from the immediate release implant.
Conclusion. The sustained delivery of BMP-2 based on the biodegradable PLGA microsphere system resulted in faster and more complete bone healing in the animal model.
- R. A. Kenley, K. Yim, J. Abrams, E. Ron, T. Turek, L. J. Marden, and J. O. Hollinger. Biotechnology and bone graft substitutes. Pharm. Res. 10:1393-1401 (1993).
- P. J. Boyne, R. E. Marx, M. Nevins, G. Triplett, E. Lazaro, L. C. Lilly, M. Alder, and P. Nummikoski. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodont. Rest. Dent. 17:11-25 (1997).
- U. Ripamonti, M. Heliotis, D. C. Rueger, and T. K. Sampath. Induction of cementogenesis by recombinant human osteogenic protein-1(hop-1/bmp-7) in the baboon (Papio ursinus). Arch. Oral. Biol. 41:121-126 (1996).
- A. J. Celeste, J. A. Iannazzi, R. C. Taylor, R. M. Hewick, V. Rosen, E. A. Wang, and J. M. Wozney. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87:9843-9847 (1990).
- E. A. Wang. Bone morphogenetic proteins (BMPs): the therapeutic potential in healing bony defects. Trends Biotechnol. 11:379-383 (1993).
- E. Özkaynak, D. C. Rueger, E. A. Drier, C. Corbett, R. J. Ridge, T. K. Sampath, and H. Oppermann. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:2085-2093 (1990).
- T. K. Sampath, J. E. Coughlin, R. M. Whetstone, D. Banach, C. Corbett, R. J. Ridge, E. Ozkaynak, and H. Oppermann. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J. Biol. Chem. 265:13198-13205 (1990).
- E. Özkaynak, P. N. Schnegelsberg, D. F. Jin, G. M. Clifford, F. D. Warren, E. A. Drier, and H. Oppermann. Osteogenic protein-2: A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J. Biol. Chem. 267:25220-25227 (1992).
- K. Elima. Osteoinductive proteins. Ann. Med. 25:395-402 (1993).
- K. Tagaki and M. R. Urist. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann. Surg. 196:100-109 (1982).
- V. Rosen and R. S. Thies. The BMP proteins in bone formation and repair. Trends Genet. 8:97-102 (1992).
- A. H. Reddi and N. S. Cunningham. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J. Bone Miner. Res. 8:S499-S502 (1993).
- E. A. Wang, D. I. Israel, S. Kelly, and D. P. Luxenberg. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9:57-71 (1993).
- I. Ono, T. Ohura, M. Murata, H. Yamaguchi, Y. Ohnuma, and Y. Kuboki. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast. Reconstr. Surg. 90:870-879 (1992).
- J. P. Levine, J. Bradley, A. E. Turk, J. L. Ricci, J. J. Benedict, G. Steine, M. T. Longaker, and J. G. McCarthy. Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit. Ann. Plast. Surg. 39:158-168 (1997).
- A. W. Yasko, J. M. Lane, E. J. Fellinger, V. Rosen, J. M. Wozney, and E. A. Wang. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biochemical study in rats. J. Bone Joint Surg. AM. 74:659-670 (1992).
- B. A. Doll, H. J. Towle, J. O. Hollinger, A. H. Reddi, and J. T. Mellonig. The osteogenic potential of two composite graft systems using osteogenin. J. Periodontol. 61:745-750 (1990).
- J. C. Moore, V. J. Matukas, J. R. Deatherage, and E. J. Miller. Craniofacial osseous restoration with osteoinductive proteins in a collagenous delivery system. Int. J. Oral Maxillofac Surg. 19:172-176 (1990).
- H. D. Zegzula, D. C. Buck, J. Brekke, J. M. Wozney, and J. O. Hollinger. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. AM. 79:1778-1790 (1997).
- T. Miki, K. Harada, Y. Imai, and S. Enomoto. Effect of freezedried poly-L-lactic acid discs mixed with bone morphogenetic protein on the healing of rat skull defects. J. Oral Maxillofac. Surg. 25:387-391 (1994).
- R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, and J. O. Hollinger. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 28:1139-1147 (1994).
- S. S. Duggirala, R. C. Mehta, and P. P. DeLuca. Interaction of recombinant morphogenetic protein-2 with poly (d,l-lactide-co-glycolide) microspheres. Pharm. Dev. Technol. 1:11-19 (1996).
- J. A. Schrier and P. P. DeLuca. Porous bone morphogenetic protein-2 microspheres: Polymer binding and in vitro release. Pharm. Sci. Tech. 2(3) article 17 (2001) [http://www.pharmscitech.com]
- Z. Schwartz, A. Somers, J. T. Mellonig, D. L. Carnes Jr, J. M. Wozney, D. D. Dean, D. L. Cochran, and B. D. Boyan. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J. Peridontol. 69:1337-1345 (1998).
- D. A. Puleo, W. W. Huh, S. S. Duggirala, and P. P. DeLuca. In vitro cellular response to bioerodible particles loaded with recombinant human morphogenetic protein-2. J. Biomed. Mater. Res. 41:104-110 (1998).
- D. A. Puleo. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J. Cell. Physiol. 173:93-101 (1997).
- J. A. Schrier and P.P. DeLuca. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. Pharm. Dev. Technol. 4:611-621 (1999).
- S. S. Duggirala, J. B. Rodgers, and P. P. DeLuca. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm. Dev. Technol. 1:165-174 (1996).
- J. A. Schrier, B. F. fink, J. B. Rodgers, H. C. Vasconez, and P. P. DeLuca. Effect of freeze-dried CMC/PLGA migrosphere matrix of BMP-2 on bone healing. Pharm. Sci. Tech. 2(3) article 18 (2001).
- H. Uludag, W. Friess, D. Williams, T. Porter, G. Timony, D. D'Augusta, C. Blake, R. Palmer, B. Biron, and J. Wozney. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann. NY Acad. Sci. 875:369-378 (1999).
- Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix
Volume 18, Issue 12 , pp 1747-1753
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- bone healing
- sustained delivery
- Industry Sectors
- Author Affiliations
- 1. Faculty of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536
- 2. Division of Plastic Surgery, Department of Surgery, College of Medicine, University of Kentucky, Lexington, Kentucky, 40536
- 3. Biotechnology Facility, Magellan Laboratories, Inc., San Diego, California, 92126